These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21327030)

  • 21. Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic.
    Hell M; Bernhofer C; Stalzer P; Kern JM; Claassen E
    Benef Microbes; 2013 Mar; 4(1):39-51. PubMed ID: 23434948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital.
    Kim J; Pai H; Seo MR; Kang JO
    J Korean Med Sci; 2011 Oct; 26(10):1258-64. PubMed ID: 22022175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical epidemiology of Clostridium difficile infection among hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.
    Lopes Cançado GG; Silveira Silva RO; Rupnik M; Nader AP; Starling de Carvalho J; Miana de Mattos Paixão G; Martins Resende BA; Faria Lobato FC; Vilela EG
    Anaerobe; 2018 Dec; 54():65-71. PubMed ID: 30114442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.
    Awad MM; Johanesen PA; Carter GP; Rose E; Lyras D
    Gut Microbes; 2014; 5(5):579-93. PubMed ID: 25483328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of toxins in Clostridium difficile infection.
    Chandrasekaran R; Lacy DB
    FEMS Microbiol Rev; 2017 Nov; 41(6):723-750. PubMed ID: 29048477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.
    Carter GP; Chakravorty A; Pham Nguyen TA; Mileto S; Schreiber F; Li L; Howarth P; Clare S; Cunningham B; Sambol SP; Cheknis A; Figueroa I; Johnson S; Gerding D; Rood JI; Dougan G; Lawley TD; Lyras D
    mBio; 2015 Jun; 6(3):e00551. PubMed ID: 26037121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.
    Polage CR; Gyorke CE; Kennedy MA; Leslie JL; Chin DL; Wang S; Nguyen HH; Huang B; Tang YW; Lee LW; Kim K; Taylor S; Romano PS; Panacek EA; Goodell PB; Solnick JV; Cohen SH
    JAMA Intern Med; 2015 Nov; 175(11):1792-801. PubMed ID: 26348734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Epidemiology and Risk Factors of
    Yang Z; Huang Q; Qin J; Zhang X; Jian Y; Lv H; Liu Q; Li M
    Front Cell Infect Microbiol; 2020; 10():578098. PubMed ID: 33425775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
    Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G
    Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of Clostridium difficile infection in hospitalized adults and the first isolation of C. difficile PCR ribotype 027 in central China.
    Zhou Y; Mao L; Yu J; Lin Q; Luo Y; Zhu X; Sun Z
    BMC Infect Dis; 2019 Mar; 19(1):232. PubMed ID: 30845918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxin synthesis by Clostridium difficile is regulated through quorum signaling.
    Darkoh C; DuPont HL; Norris SJ; Kaplan HB
    mBio; 2015 Feb; 6(2):e02569. PubMed ID: 25714717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical, epidemiological and microbiological characteristics of relapse and re-infection in Clostridium difficile infection.
    Gómez S; Chaves F; Orellana MA
    Anaerobe; 2017 Dec; 48():147-151. PubMed ID: 28830842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ribotypes associated with Clostridium difficile outbreaks in Brazil display distinct surface protein profiles.
    Ferreira TG; Moura H; Barr JR; Pilotto Domingues RMC; Ferreira EO
    Anaerobe; 2017 Jun; 45():120-128. PubMed ID: 28435010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing prevalence of the epidemic ribotype 106 in healthcare facility-associated and community-associated Clostridioides difficile infection.
    Suárez-Bode L; Barrón R; Pérez JL; Mena A
    Anaerobe; 2019 Feb; 55():124-129. PubMed ID: 30550807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent
    Navalkele BD; Chopra T
    Biologics; 2018; 12():11-21. PubMed ID: 29403263
    [No Abstract]   [Full Text] [Related]  

  • 36. A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster Model.
    Anosova NG; Cole LE; Li L; Zhang J; Brown AM; Mundle S; Zhang J; Ray S; Ma F; Garrone P; Bertraminelli N; Kleanthous H; Anderson SF
    Clin Vaccine Immunol; 2015 Jul; 22(7):711-25. PubMed ID: 25924765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium difficile ribotype 176 - A predictor for high mortality and risk of nosocomial spread?
    Polivkova S; Krutova M; Petrlova K; Benes J; Nyc O
    Anaerobe; 2016 Aug; 40():35-40. PubMed ID: 27155489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.
    Anosova NG; Brown AM; Li L; Liu N; Cole LE; Zhang J; Mehta H; Kleanthous H
    J Med Microbiol; 2013 Sep; 62(Pt 9):1394-1404. PubMed ID: 23518659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host response to Clostridium difficile infection: Diagnostics and detection.
    Usacheva EA; Jin JP; Peterson LR
    J Glob Antimicrob Resist; 2016 Dec; 7():93-101. PubMed ID: 27693863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clostridium difficile carriage in adult cystic fibrosis (CF); implications for patients with CF and the potential for transmission of nosocomial infection.
    Burke DG; Harrison MJ; Fleming C; McCarthy M; Shortt C; Sulaiman I; Murphy DM; Eustace JA; Shanahan F; Hill C; Stanton C; Rea MC; Ross RP; Plant BJ
    J Cyst Fibros; 2017 Mar; 16(2):291-298. PubMed ID: 27908697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.